AKT1 and nasopharyngeal carcinoma: To further determine the effect of Akt in NPC cells, CNE2 cells were treated with phosphotidylinsitol-3-kinase inhibitor (LY294002, Cell Signaling) at different concentrations (0, 20, 50, 100 μmol/L).